PR Newswire
Alzamend Neuro Initiates Phase II Clinical Trial of AL001 "Lithium in Brain" Study in Patients with Bipolar Disorder in Collaboration with Massachusetts General Hospital
📊
AI Sentiment
Positive
7/10
Alzamend Neuro Inc. News
Latest updates and market news for ALZN
1 news
Mar 15 - Mar 21, 2026
Page 1
Share this news page